Omnicell Makes a Move: Up 1.5%

Print Share

Dec 19, 2012 (Market movers via COMTEX) -- Omnicell (NASDAQ:OMCL), a company whose shares are moving quickly, is trading 1.5% higher to $16.05. The S&P is trading fractionally lower to 1,445 and the Dow is trading fractionally lower to 13,348.

There is potential upside of 10.1% for shares of Omnicell based on a current price of $16.05 and an average consensus analyst price target of $17.67. The stock should discover initial support at its 50-day moving average (MA) of $14.57 and subsequent support at its 200-day MA of $14.36.

Over the past year, Omnicell has traded in a range of $12.33 to $18.15 and is now at $16.05, 30% above that low. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 1.4%.

Omnicell, Inc. provides an integrated suite of clinical infrastructure and workflow automation solutions for healthcare facilities. The Company's solutions include pharmacy and supply systems, clinical reference tools, an Internet-based procurement application, and decision support tools. Omnicell sells and leases its products and services to a range of healthcare facilities.


Financial News Network Online (FNNO) is a leading provider of digital financial news content for distribution on the web. You can count on FNNO to bring you the latest market news, earnings reports, analyst comments, economic data reports and more. Visit today.

Copyright, Comtex News Network, Inc. 2012

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.